Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864–84. https://doi.org/10.1038/s41571-023-00825-3.

Article  PubMed  Google Scholar 

Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers. 2023;15(2):533. https://doi.org/10.3390/cancers15020533.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang C, Liu J, Yan Y, Tan Y. Role of exosomes in chronic liver disease development and their potential clinical applications. J Immunol Res. 2022;2022:1695802. https://doi.org/10.1155/2022/1695802.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Advances in radiotherapy and immunity in hepatocellular carcinoma. J Transl Med. 2023;21(1):526. https://doi.org/10.1186/s12967-023-04386-y.

Article  PubMed  PubMed Central  Google Scholar 

Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(4):203–22. https://doi.org/10.1038/s41575-022-00704-9.

Article  PubMed  Google Scholar 

Stenger Moura FC, dos Santos Machado CL, Reisdorfer Paula F, Garcia Couto A, Ricci M, Cechinel-Filho V, Bonomini TJ, Sandjo LP, Bellé Bresolin TM. Taxifolin stability: in silico prediction and in vitro degradation with HPLC-UV/UPLC–ESI-MS monitoring. J Pharm Anal. 2021;11(2):232–40. https://doi.org/10.1016/j.jpha.2020.06.008.

Article  PubMed  Google Scholar 

Li W, Zhang L, Xu Q, Yang W, Zhao J, Ren Y, Yu Z, Ma L. Taxifolin alleviates DSS-induced ulcerative colitis by acting on gut microbiome to produce butyric acid. Nutrients. 2022;14(5):1069. https://doi.org/10.3390/nu14051069.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sunil C, Xu B. An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry. 2019;166: 112066. https://doi.org/10.1016/j.phytochem.2019.112066.

Article  CAS  PubMed  Google Scholar 

Vladimirov YA, Proskurnina EV, Demin EM, Matveeva NS, Lubitskiy OB, Novikov AA, Izmailov DY, Osipov AN, Tikhonov VP, Kagan VE. Dihydroquercetin (taxifolin) and other flavonoids as inhibitors of free radical formation at key stages of apoptosis. Biochemistry. 2009;74(3):301–7. https://doi.org/10.1134/s0006297909030092.

Article  CAS  PubMed  Google Scholar 

Lin Z, Wang J. Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway. Heliyon. 2023;9(11): e22011. https://doi.org/10.1016/j.heliyon.2023.e22011.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu L, Zhang L, Zhang S, Yang J, Zhu A, Sun J, Kalvakolanu DV, Cong X, Zhang J, Tang J, Guo B. Taxifolin inhibits melanoma proliferation/migration impeding USP18/Rac1/JNK/β-catenin oncogenic signaling. Phytomedicine. 2024;123: 155199. https://doi.org/10.1016/j.phymed.2023.155199.

Article  CAS  PubMed  Google Scholar 

Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. https://doi.org/10.1038/s41392-022-01229-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Cai Q, Liang R, Zhang D, Liu X, Zhang M, Xiong Y, Xu M, Liu Q, Li P, Yu P, Shi A. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis. 2023;14(2):105. https://doi.org/10.1038/s41419-023-05639-w.

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Feng Q, Luan Y, Liu H, Jiao Y, Hao H, Yu B, Luan Y, Ren K. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases. Front Pharmacol. 2023;14:1229297. https://doi.org/10.3389/fphar.2023.1229297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Gong P, Su L, Zhang M. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Sci Rep. 2023;13(1):20870. https://doi.org/10.1038/s41598-023-47223-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quan B, Liu W, Yao F, Li M, Tang B, Li J, Ren Z, Yin X. LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13(11):5590–609.

CAS  PubMed  PubMed Central  Google Scholar 

Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, Feng T, Cui Z, Zhu T, Li Y, Qiu Z, Fan G, Huang C. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523. https://doi.org/10.1038/s41467-023-42025-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilcock DJ, Badrock AP, Wong CW, Owen R, Guerin M, Southam AD, Johnston H, Telfer BA, Fullwood P, Watson J, Ferguson H, Ferguson J, Lloyd GR, Jankevics A, Dunn WB, Wellbrock C, Lorigan P, Ceol C, Francavilla C, Smith MP, Hurlstone AFL. Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached. Cell Rep. 2022;39(12): 110995. https://doi.org/10.1016/j.celrep.2022.110995.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Walker RA, Sharman PA, Miller CM, Lippuner C, Okoniewski M, Eichenberger RM, Ramakrishnan C, Brossier F, Deplazes P, Hehl AB, Smith NC. RNA Seq analysis of the Eimeria tenella gametocyte transcriptome reveals clues about the molecular basis for sexual reproduction and oocyst biogenesis. BMC Genomics. 2015;16(1):94. https://doi.org/10.1186/s12864-015-1298-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo G, Wang L, Zheng Z, Gao B, Lei C. Cuproptosis-related ferroptosis genes for predicting prognosis in kidney renal clear cell carcinoma. Eur J Med Res. 2023;28(1):176. https://doi.org/10.1186/s40001-023-01137-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q, Li R, Wu H, Liang Z. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma. BMC Cancer. 2023;23(1):226. https://doi.org/10.1186/s12885-023-10678-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108–18. https://doi.org/10.1016/j.ejca.2021.11.023.

Article  PubMed  Google Scholar 

Parra NS, Ross HM, Khan A, Wu M, Goldberg R, Shah L, Mukhtar S, Beiriger J, Gerber A, Halegoua-DeMarzio D. Advancements in the diagnosis of hepatocellular carcinoma. Int J Transl Med. 2023;3:51–65. https://doi.org/10.3390/ijtm3010005.

Article  Google Scholar 

Das A, Baidya R, Chakraborty T, Samanta AK, Roy S. Pharmacological basis and new insights of taxifolin: a comprehensive review. Biomed Pharmacother. 2021;142: 112004. https://doi.org/10.1016/j.biopha.2021.112004.

Article  CAS  PubMed  Google Scholar 

Alves MC, de Almeida PA, Polonini HC, Bhering CAP, de Ferreira OA, Brandao MAF, Raposo NRB. Taxifolin: evaluation through ex vivo permeations on human skin and porcine vaginal mucosa. Curr Drug Deliv. 2018;15(8):1123–34. https://doi.org/10.2174/1567201815666180116090258.

Article  CAS  PubMed  Google Scholar 

Liu Y, Shi X, Tian Y, Zhai S, Liu Y, Xiong Z, Chu S. An insight into novel therapeutic potentials of taxifolin. Front Pharmacol. 2023;14:1173855. https://doi.org/10.3389/fphar.2023.1173855.

Article  CAS  PubMed